Myths vs facts: TCF7L2 and Blutzucker

TCF7L2 is one of the most robustly replicated risk genes for type 2 diabetes. GWAS meta-analyses show that carriers of the risk variant (e.g., rs7903146) have an approximately 1.4- to 1.5-fold increased diabetes risk. **Myth:** The variant directly causes high blood sugar. **Fact:** The effect is modest and strongly modulated by lifestyle (diet, exercise, weight). The variant impairs insulin secretion, not insulin resistance. Clinically, the predictive value of a single SNP is low – it explains only about 1 % of diabetes variance. Direct-to-consumer tests like MyBody-X can detect this SNP, but the resulting recommendations (e.g., eat more fiber) are generic and not genotype-specific. A genotype-based dietary change alone is not evidence-based. **Conclusion:** TCF7L2 is a real risk factor, but not destiny. Its individual predictive power is limited. For blood sugar management, established screening parameters (fasting glucose, HbA1c) and lifestyle interventions are far more relevant.